Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments.
Saved in:
| Title: | Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments. |
|---|---|
| Authors: | Akazawa D; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Ohashi H; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Hishiki T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Morita T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Iwanami S; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan., Kim KS; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.; Department of Science System Simulation, Pukyong National University, Busan, South Korea.; Department of Mathematics, Pusan National University, Busan, South Korea., Jeong YD; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.; Department of Mathematics, Pusan National University, Busan, South Korea., Park ES; Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan., Kataoka M; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan., Shionoya K; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.; Department of Applied Biological Science, Tokyo University of Science, Noda, Japan., Mifune J; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Tsuchimoto K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Ojima S; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Azam AH; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Nakajima S; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan., Park H; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan., Yoshikawa T; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan., Shimojima M; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan., Kiga K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Iwami S; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.; Institute of Mathematics for Industry, Kyushu University, Fukuoka, Japan.; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.; Interdisciplinary Theoretical and Mathematical Sciences Program, RIKEN, Saitama, Japan.; NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan.; Science Groove, Inc, Fukuoka, Japan.; MIRAI, Japan Science and Technology Agency, Saitama, Japan., Maeda K; Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan., Suzuki T; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan., Ebihara H; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan., Takahashi Y; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Watashi K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.; Department of Applied Biological Science, Tokyo University of Science, Noda, Japan.; MIRAI, Japan Science and Technology Agency, Saitama, Japan. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2023 Aug 31; Vol. 228 (5), pp. 591-603. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36892247 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Akazawa+D%22">Akazawa D</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ohashi+H%22">Ohashi H</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hishiki+T%22">Hishiki T</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Morita+T%22">Morita T</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Iwanami+S%22">Iwanami S</searchLink>; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Kim+KS%22">Kim KS</searchLink>; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.; Department of Science System Simulation, Pukyong National University, Busan, South Korea.; Department of Mathematics, Pusan National University, Busan, South Korea.<br /><searchLink fieldCode="AU" term="%22Jeong+YD%22">Jeong YD</searchLink>; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.; Department of Mathematics, Pusan National University, Busan, South Korea.<br /><searchLink fieldCode="AU" term="%22Park+ES%22">Park ES</searchLink>; Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kataoka+M%22">Kataoka M</searchLink>; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shionoya+K%22">Shionoya K</searchLink>; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.; Department of Applied Biological Science, Tokyo University of Science, Noda, Japan.<br /><searchLink fieldCode="AU" term="%22Mifune+J%22">Mifune J</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tsuchimoto+K%22">Tsuchimoto K</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ojima+S%22">Ojima S</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Azam+AH%22">Azam AH</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nakajima+S%22">Nakajima S</searchLink>; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Park+H%22">Park H</searchLink>; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshikawa+T%22">Yoshikawa T</searchLink>; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shimojima+M%22">Shimojima M</searchLink>; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kiga+K%22">Kiga K</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Iwami+S%22">Iwami S</searchLink>; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.; Institute of Mathematics for Industry, Kyushu University, Fukuoka, Japan.; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.; Interdisciplinary Theoretical and Mathematical Sciences Program, RIKEN, Saitama, Japan.; NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan.; Science Groove, Inc, Fukuoka, Japan.; MIRAI, Japan Science and Technology Agency, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Maeda+K%22">Maeda K</searchLink>; Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+T%22">Suzuki T</searchLink>; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ebihara+H%22">Ebihara H</searchLink>; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+Y%22">Takahashi Y</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Watashi+K%22">Watashi K</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.; Department of Applied Biological Science, Tokyo University of Science, Noda, Japan.; MIRAI, Japan Science and Technology Agency, Saitama, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2023 Aug 31; Vol. 228 (5), pp. 591-603. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36892247 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiad058 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 591 Titles: – TitleFull: Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Akazawa D – PersonEntity: Name: NameFull: Ohashi H – PersonEntity: Name: NameFull: Hishiki T – PersonEntity: Name: NameFull: Morita T – PersonEntity: Name: NameFull: Iwanami S – PersonEntity: Name: NameFull: Kim KS – PersonEntity: Name: NameFull: Jeong YD – PersonEntity: Name: NameFull: Park ES – PersonEntity: Name: NameFull: Kataoka M – PersonEntity: Name: NameFull: Shionoya K – PersonEntity: Name: NameFull: Mifune J – PersonEntity: Name: NameFull: Tsuchimoto K – PersonEntity: Name: NameFull: Ojima S – PersonEntity: Name: NameFull: Azam AH – PersonEntity: Name: NameFull: Nakajima S – PersonEntity: Name: NameFull: Park H – PersonEntity: Name: NameFull: Yoshikawa T – PersonEntity: Name: NameFull: Shimojima M – PersonEntity: Name: NameFull: Kiga K – PersonEntity: Name: NameFull: Iwami S – PersonEntity: Name: NameFull: Maeda K – PersonEntity: Name: NameFull: Suzuki T – PersonEntity: Name: NameFull: Ebihara H – PersonEntity: Name: NameFull: Takahashi Y – PersonEntity: Name: NameFull: Watashi K IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 08 Text: 2023 Aug 31 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 228 – Type: issue Value: 5 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |